Inhibition of platelet MAO-B by kava pyrone-enriched extract from Piper methysticum Forster (kava-kava)
- PMID: 9832350
- DOI: 10.1055/s-2007-979325
Inhibition of platelet MAO-B by kava pyrone-enriched extract from Piper methysticum Forster (kava-kava)
Abstract
Kava-kava, a psychoactive beverage, induces relaxation, improves social interaction, promotes sleep and plays an important role in the sociocultural life in the islands of the South Pacific. On the other hand, standardized extracts of kava-kava roots are used for the therapy of anxiety, tension and restlessness. Kava pyrones, the major constituents of kava kava, are generally considered to be responsible for the pharmacological activity in humans and animals. To obtain more information on the mechanisms by which kava-kava exerts psychotropic properties we investigated the in vitro effects of kava-kava extract and pure synthetic kava pyrones on human platelet MAO-B, in comparison to amitriptyline, imipramine and brofaromine. Kava-kava extract was found to be a reversible inhibitor of MAO-B in intact platelets (IC50 24 microM) and disrupted platelet homogenates (IC50 1.2 microM). Structural differences of kava pyrones resulted in a different potency of MAO-B inhibition. The order of potency was desmethoxyyangonin > (+/-)-methysticin > yangonin > (+/-)-dihydromethysticin > (+/-)- dihydrokavain > (+/-)-kavain. The two most potent kava pyrones, desmethoxyyangonin and (+/-)-methysticin displayed a competetive inhibition pattern with mean Ki 0.28 microM and 1.14 microM respectively. The inhibition of MAO-B by kava pyrone-enriched extracts might be an important mechanism for their psychotropic activity.
Similar articles
-
Monoamine Oxidase Inhibition by Kavalactones from Kava (Piper Methysticum).Planta Med. 2019 Oct;85(14-15):1136-1142. doi: 10.1055/a-1008-9491. Epub 2019 Sep 20. Planta Med. 2019. PMID: 31539917
-
Extracts and kavalactones of Piper methysticum G. Forst (kava-kava) inhibit P-glycoprotein in vitro.Drug Metab Dispos. 2005 Nov;33(11):1580-3. doi: 10.1124/dmd.105.005892. Epub 2005 Jul 28. Drug Metab Dispos. 2005. PMID: 16051732
-
Interaction of various Piper methysticum cultivars with CNS receptors in vitro.Planta Med. 2001 Jun;67(4):306-11. doi: 10.1055/s-2001-14334. Planta Med. 2001. PMID: 11458444
-
[Kava-kava preparations--alternative anxiolytics].Pol Merkur Lekarski. 1998 Mar;4(21):179-180a. Pol Merkur Lekarski. 1998. PMID: 9640076 Review. Polish.
-
Kava: a comprehensive review of efficacy, safety, and psychopharmacology.Aust N Z J Psychiatry. 2011 Jan;45(1):27-35. doi: 10.3109/00048674.2010.522554. Epub 2010 Nov 15. Aust N Z J Psychiatry. 2011. PMID: 21073405 Review.
Cited by
-
Roles of selected non-P450 human oxidoreductase enzymes in protective and toxic effects of chemicals: review and compilation of reactions.Arch Toxicol. 2022 Aug;96(8):2145-2246. doi: 10.1007/s00204-022-03304-3. Epub 2022 Jun 1. Arch Toxicol. 2022. PMID: 35648190 Free PMC article. Review.
-
Ex vivo and in vitro inhibitory potential of Kava extract on monoamine oxidase B activity in mice.J Tradit Complement Med. 2021 Jul 14;12(2):115-122. doi: 10.1016/j.jtcme.2021.07.002. eCollection 2022 Mar. J Tradit Complement Med. 2021. PMID: 35528470 Free PMC article.
-
Translational Informatics for Natural Products as Antidepressant Agents.Front Cell Dev Biol. 2022 Jan 20;9:738838. doi: 10.3389/fcell.2021.738838. eCollection 2021. Front Cell Dev Biol. 2022. PMID: 35127696 Free PMC article. Review.
-
Kava as a Clinical Nutrient: Promises and Challenges.Nutrients. 2020 Oct 5;12(10):3044. doi: 10.3390/nu12103044. Nutrients. 2020. PMID: 33027883 Free PMC article. Review.
-
Synthetic Kavalactone Analogues with Increased Potency and Selective Anthelmintic Activity against Larvae of Haemonchus contortus In Vitro.Molecules. 2020 Apr 24;25(8):2004. doi: 10.3390/molecules25082004. Molecules. 2020. PMID: 32344703 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
